US Thyroid Cancer Market 2015 Trends & 2019 Opportunities adds "US Thyroid Cancer Market: Trends and Opportunities (2015 - 2019)" report to its research store.

The report titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market. The report assesses thyroid cancer types, stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.

Product Coverage

  • Thyroid Cancer Diagnostic Surgeries
  • Thyroid Cancer Histopathology Market
  • Thyroid Cancer Secondary Surgery
  • Thyroid Cancer Hormone Replacement

Complete report available at

FNA biopsies Company Coverage

  • Veracyte Inc.
  • Mylan Inc.
  • Forest Laboratories
  • Abott Laboratories
  • Oxigene Inc.

Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases.

On the back of high incidence of thyroid cancer, it is anticipated that the thyroid cancer market in US will observe impressive double digit growth in next five years. The thyroid cancer diagnosis market is segmented into diagnostic surgeries, histopathology, secondary surgery and annual new patient hormone replacement therapy. The diagnostic technology has improved since 2011 and with use of Afirma GEC test and Afirma FNA; the detection of even minor nodules has become possible.

Purchase a copy of this research report at USD 800 (Single User License)

Few Points from Table of Contents

1. Executive Summary

2. United States Thyroid Cancer Market: An Introduction

3. US Thyroid Cancer Market: Sizing and Growth

4. US Thyroid Cancer Market Segmentation

5. U.S Thyroid Cancer Diagnosis Market: By FNA volume

6. Market Dynamics: US Thyroid Cancer Diagnosis Market

7. Competitive Landscape: U.S Thyroid Cancer Diagnosis Market

8. Company Profiles: U.S Thyroid Cancer Diagnosis Market

List of Tables

Table1: TNM Classification for Differentiated Thyroid Cancer

Table 2: FDA Approved drugs for thyroid cancer treatment

Table 3: Investigational agents for thyroid cancer

Table 4: 5-Year and 10-Year Surviaval Rate by cancer type

Table 5: U.S Major Players of Thyroid Cancer Market

List of Figures

Explore more Pharmaceuticals market research as well as other newly published reports by Daedal Research at

About Us:

MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:

Ritesh Tiwari

Corporate Office

TX, Dallas North - Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas 75252.

Tel: + 1 888 391 5441